← Back to patent-cliff list
HRS-1780
Tier C — Watch / tradeHRS-1780
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：MR
Indications (approved)：Hypertension, Chronic renal impairment, 醛固酮增多症, Heart failure, Type 2 diabetes, End-stage renal disease, Kidney disease
Regional status
US
-
EU
-
China
Phase III
2026-03-13
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of HRS-1780?
Approved indications include: Hypertension, Chronic renal impairment, 醛固酮增多症, Heart failure, Type 2 diabetes, End-stage renal disease, Kidney disease.
When does the HRS-1780 patent expire?
No public expiry year is available for HRS-1780 yet; this page updates once verified.
How do I get a quote for HRS-1780 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29